We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Sep 2021 - 25 Sep 2021

Global Urinalysis Market Projected to Reach Nearly USD 5 Billion by 2026

By LabMedica International staff writers
Posted on 24 Aug 2021
Print article
The global urinalysis market is projected to grow at a CAGR of 7.2% from USD 3.5 billion in 2021 to nearly USD 4.9 billion by 2026, driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and subsequent increase in age-associated diseases, and growing adoption of POC diagnostic tests.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company.

Based on product, the consumables segment accounted for the largest share of the urinalysis market in 2020 due to frequent purchase of these products as a result of their recurrent usage. Based on test type, the sediment urinalysis segment recorded the highest growth in 2020 which can be primarily attributed to the increasing adoption of automated devices for sediment analysis. Based on application, the disease screening segment held the largest share of the urinalysis market in 2020 due to increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide. Based on end user, diagnostic laboratories accounted for the largest share of the urinalysis market in 2020 owing to the rapidly growing aging population, rising global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals and the launch of advanced urinalysis devices such as integrated devices.

Geographically, North America held the largest share of the global market urinalysis market in 2020 which can be attributed to the growing geriatric population, implementation of favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically-advanced instruments in the region.

Related Links:

Gold Supplier
Fluorimetric Immunoassay Analyzer
Confiscope F20
Silver Supplier
COVID-19 NAb Test Solution
COVID-19 NAb Test Solution
Urea Breath Test System for H. Pylori
BreathID Hp Lab
Single Channel Pipette
AHN pipet4u pro

Print article



view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.